CHORMAN THOMAS E sold $14K of SXI
CHORMAN THOMAS E sold 50 shares of STANDEX INTERNATIONAL CORP/DE/ (SXI) at $272.82 on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because it is explicitly a pre-arranged Rule 10b5-1 plan, the disclosure is usually treated as administrative rather than a new fundamental signal.
Market read
This is a routine insider sale disclosure; without additional corporate news, trading impact is expected to be limited.
What to watch
The article provides only the sale size and plan type; it does not indicate whether sales are part of a larger ongoing program or whether other insiders bought/sold around the same time.
Background
The article is an SEC Form 4 insider transaction disclosure (director sale) for STANDEX INTERNATIONAL.
Ticker impact
SEC Form 4 shows director CHORMAN THOMAS E sold 50 shares of STANDEX INTERNATIONAL on 2026-06-01 at $272.82 via a 10b5-1 plan.
Likely minimal; any effect would be short-lived unless accompanied by other disclosures or operational news.
The filing is a routine, pre-arranged 10b5-1 open-market sale by a director, with no accompanying guidance, deal, or financial result in the article.
Market effects
None—single-company insider transaction with no sector-wide read-through provided.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated or unusually sized sales can be watched as a sentiment check, especially if price is already under pressure.
Key entities
- issuerSTANDEX INTERNATIONAL CORP/DE/
Subject of the SEC Form 4 insider transaction; director sold shares under a 10b5-1 plan.
- insiderCHORMAN THOMAS E
Director who executed the open-market sale disclosed in the Form 4.
